Alexandra Lansky
Latest contributions
How a new generation of coronary sinus reducer can significantly expand treatment options for patients with coronary microvascular dysfunction
21 May 2025 – From EuroPCR 2025
Discover the latest on managing coronary microvascular dysfunction (CMD) with insights from EuroPCR 2025. This session explores how physiology testing helps identify CMD endotypes in the cathlab and highlights the limitations of ETT for patients experiencing angina or dyspnea at rest. Learn about the A-FLUX coronary...
Treatment and prognostic stratification of ACS patients with cardiogenic shock
21 May 2025 – From EuroPCR 2025
This session focuses on treatment and prognostic stratification in ACS patients complicated by cardiogenic shock. Topics include mechanical CPR device performance, SCAI shock grade dynamics, hemorrhagic event predictors, ECMO-related strategies, and evaluation of BCIS conveyance algorithms for out-of-hospital cardiac arrest.
Cardiovascular intervention for chronic heart failure: where do we stand?
15 May 2024 – From EuroPCR 2024
Cardiogenic shock in women : different cause, different treatment
15 May 2024 – From EuroPCR 2024
This session will feature selected EuroPCR 2024 Clinical Case submissions focused on cardiogenic shock in women. Attendees will have the opportunity to learn about the proposed diagnoses and treatments, as well as the actual outcomes, for these challenging cases. The session will also include discussions and...
Hotline: advances in coronary physiology
14 May 2024 – From EuroPCR 2024
This hotline session explores the latest advancements in coronary physiology and their implications for percutaneous coronary intervention (PCI). Topics covered include the influence of pathophysiological patterns of coronary artery disease on the safety and efficacy of PCI, the prognostic value of myocardial ischemic burden in STEMI...
TRISCEND, ACURATE neo2, the LuX-Valve System: Top Late-Breaking Trials from PCR London Vaves 2022
27 Nov 2022 – From PCR London Valves 2022
Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions and learn more about the latest evidence evidence concerning new transcatheter valve devices, emerging innovative devices as well as highlighted content from the EuroIntervention journal.
Hot TAVI topics - Cerebral embolic protection
27 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about the latest data concerning cerebral embolic protection (CEP) in TAVI, to find out about currently available and emerging embolic protection devices and to get a better understanding of variations in head and neck vessel anatomy and tips and tricks...
EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary physiology: DECISION QFR, INOCA, and PROPHET-FFR
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in coronary physiology! Angiography-derived coronary microcirculatory assessment in INOCA patients, Heart Team decision-making based on angiography-derived FFR: DECISION QFR, and safety and efficacy of post-PCI physiological assessment: PROPHET-FFR.
A randomised study comparing imaging guided implantation of Orsiro and Xience - CASTLE study
20 May 2021 – From EuroPCR 2021
Watch this LBT session, which was originally presented during EuroPCR 2021, to find out more about the CASTLE study, whose aim is to access the results of two types of DES implanted with image guidance in all-comers.
Leading with evidence, latest clinical outcomes update for Firesorb, Firehawk and VitaFlow
19 May 2021 – From EuroPCR 2021
Watch this session presented by Alexandra Lansky, Andreas Baumbauch, Junbo Ge and Bo Xu in order to learn about the one-year results from a pivotal RCT (FUTURE II), the four-year results from TARGET AC, and the four-year results from VitaFlow transcatheter aortic valve system in patients with severe aortic...
One-year results from the FUTURE-II trial
19 May 2021 – From EuroPCR 2021
This LBT session, which was originally presented during EuroPCR 2021, deals with the FUTURE-II study on the new generation of bioresorbable scaffolds, providing comparative safety and efficacy evidence of the thinner-strut PLLA-based BRS in the treatment of patients with noncomplex coronary lesions.
TAVI in 2020 is a routine low risk procedure: where can we do better?
22 Nov 2020 – From PCR Valves e-Course 2020
Watch this session if you want to learn how refinements in pre-, peri- and post-procedural care can enhance TAVI safety and efficacy, to integrate the latest clinical evidence into your daily clinical practice and to translate these insights into improved outcomes for your patients.
This session was...
Target all comers 3-year results - Evaluation of Cobalt Chrome Rapamycin Drug Eluting Stent
25 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to review the Firehawk family TES technology and early clinical outcomes in the treatment of atherosclerotic lesions, to gain the first sight of the 3-year results of the TARGET AC trial and to look into the Future Directions of Target...
Hotlines and innovations on stents & scaffolds - PCR e-Course 2020
25 Jun 2020 – From PCR e-Course 2020
View a selection of hot lines from PCR e-Course 2020 on the topic of stents & scaffolds:
- Advances in coronary stenting - Outcome of thinnest strut DES
- TARGET All Comers Trial- three-year Results
- Final results of the REMEDEE registry
- e-ULTIMASTER registry: final results and differences across continents
- Main results of the Biofreedom...
Kenneth M. Kent, MD, PhD (1938-2020): a eulogy
19 May 2020
Kenny Kent was very influential in setting up the new specialty of Interventional Cardiology based on well collected and adjudicated data, which paved the path for the subsequent randomized clinical trials. Without his contributions, our specialty may have been like many others in Medicine, just an...
Author
Author
Case-based learning for the Heart Valve Team: bioprosthetic valve thrombosis
18 Nov 2019 – From PCR London Valves 2019
Consult this session on bioprosthetic valve thrombosis to learn more about its detection and management, with a focus on the key role of imaging in the follow-up of patients, and discover how to identify patients at high risk of thrombosis or bleeding and their optimal management.
Introduction to the PCR London Valves 2019 Aortic Track - The key questions in TAVI: where are we in 2019?
18 Nov 2019 – From PCR London Valves 2019
Consult this session on the key questions in TAVI to learn more about the challenges, the latest evidence addressing the unresolved questions (durability, concomitant CAD, reaccess, asymptomatic AS...) and how to apply this information in your daily clinical practice.
TAVI and stroke prevention
Systematic imaging has shown silent injury to the brain in the vast majority of TAVI patients. Jean-Philippe Collet (France) asks Alexandra Lansky (USA and UK) about the incidence, risk factors and protection in periprocedural stroke. From explaining the mechanical causes and the rates of clinical and...
TAVI and stroke prevention
24 May 2019 – From EuroPCR 2019
Consult this session to learn all about how to prevent stroke during TAVI, especially in patients at high risk for cerebral embolism or with atrial fibrillation, through cerebral protection devices, anticoagulation, LAA closure, and more!
Latest clinical and technology update of Firehawk Target eluting stent platform
23 May 2019 – From EuroPCR 2019
Consult this session to discover all about the latest clinical and technology update of Firehawk Target eluting stent platform, the results and insights of Target AC trial 2-year follow-up, and more!
Latest developments in cerebral embolic protection
23 May 2019 – From EuroPCR 2019
Consult this session to hear the latest update on the US REFLECT phase II trial, to learn about the EU experience with the TriGUARD 3 CEP device and to learn about Keystone Heart's EU roadmap.
Clinical value of DEB for coronary intervention
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about the clinical value of drug-eluting baloons thanks to various studies and trials: PREVAIL, ELEGANT, and more!
PCR statement on the future of paclitaxel drug-coated balloons
Up until December 2018, drug-coated balloons (DCBs) were considered the standard of care in superficial femoral artery (SFA) disease. However, a meta-analysis published by Katsanos and colleagues in JAHA in 2018 has challenged the safety of paclitaxel DCBs for that indication. Should physicians therefore change their...
Optimising the generation and regulatory application of clinical evidence in the European Union and the United States
22 May 2019 – From EuroPCR 2019
Consult this session to discover innovative approaches for collecting and utilising clinical evidence, and learn more about how to conduct efficient clinical research to support marketing approval in the European Union, the United States, or regions dependent on the CE mark or FDA approval.
Coronary lithotripsy for stent underexpansion
22 May 2019 – From EuroPCR 2019
Consult this session to learn more about coronary lithotripsy for stent underexpansion, and discover a selection of compelling cases: late stent thrombosis caused by severe stent underexpansion, delivering a stent through double layer of underexpanded stents implanted in heavily calcified plaque, and more!
PCR STATEMENT on clinical outcomes after interventions with paclitaxel drug-coated balloons
21 May 2019
Paris, France, 21 May 2019. This PCR statement on paclitaxel drug-coated balloons (DCB) use in peripheral interventions addresses the controversy raised by the meta-analysis of K. Katsanos, MD, PhD (Patras University Hospital, Rion, Greece) and colleagues, published in late 2018 (https://doi.org/10.1161/JAHA.118.011245). The Katsanos meta-analysis prompted widespread...
Trials and registries - Clinical outcomes after interventions with drug-coated balloons
21 May 2019 – From EuroPCR 2019
Consult this session to learn more about the results of the latest trials and registries regarding the clinical outcomes after interventions with drug-coated balloons: SCAAR, BASKET-SMALL 2, EASTBOURNE, and more!
A word from our sponsors
20 May 2019 – From PCR Innovators Day 2019
Stroke treatment and prevention
20 May 2019 – From PCR Innovators Day 2019
Out of the box technologies
20 May 2019 – From PCR Innovators Day 2019